Julia B. Lewis, M.D.


Faculty Appointments
Professor of Medicine
M.D., Medicine, University of Illinois, Urbana-Champaign, IllinoisB.S., GPA 4.0, University of Illinois, Urbana-Champaign, Illinois
Office Address
S-3223 MCN
TN 2372
McCoy AB, Waitman LR, Lewis JB, Wright JA, Choma DP, Miller RA, Peterson JF. A framework for evaluating the appropriateness of clinical decision support alerts and responses. J Am Med Inform Assoc [print-electronic]. 2012 May; 19(3): 346-52. PMID: 21849334, PMCID: PMC3341775, PII: amiajnl-2011-000185, DOI: 10.1136/amiajnl-2011-000185, ISSN: 1527-974X.

Persson F, Lewis JB, Lewis EJ, Rossing P, Hollenberg NK, Hans-Henrik P. Impact of aliskiren treatment on urinary aldosterone levels in patients with type 2 diabetes and nephropathy: an AVOID substudy. J Renin Angiotensin Aldosterone Syst [print-electronic]. 2012 Mar; 13(1): 118-21. PMID: 21824990, PII: 1470320311417272, DOI: 10.1177/1470320311417272, ISSN: 1752-8976.

Packham DK, Alves TP, Dwyer JP, Atkins R, de Zeeuw D, Cooper M, Shahinfar S, Lewis JB, Lambers Heerspink HJ. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database. Am. J. Kidney Dis [print-electronic]. 2012 Jan; 59(1): 75-83. PMID: 22051245, PII: S0272-6386(11)01406-5, DOI: 10.1053/j.ajkd.2011.09.017, ISSN: 1523-6838.

Lewis EJ, Greene T, Spitalewiz S, Blumenthal S, Berl T, Hunsicker LG, Pohl MA, Rohde RD, Raz I, Yerushalmy Y, Yagil Y, Herskovits T, Atkins RC, Reutens AT, Packham DK, Lewis JB, . Pyridorin in type 2 diabetic nephropathy. J. Am. Soc. Nephrol [print-electronic]. 2012 Jan; 23(1): 131-6. PMID: 22034637, PMCID: PMC3269925, PII: ASN.2011030272, DOI: 10.1681/ASN.2011030272, ISSN: 1533-3450.

Morgado P, Lewis JB, Laginhas CM, Martins LF, McCabe C, Blas FJ, Filipe EJ. Systems involving hydrogenated and fluorinated chains: volumetric properties of perfluoroalkanes and perfluoroalkylalkane surfactants. J Phys Chem B [print-electronic]. 2011 Dec 12/22/2011; 115(50): 15013-23. PMID: 21950377, DOI: 10.1021/jp207567y, ISSN: 1520-5207.

Dwyer JP, Lewis JB. Olmesartan to prevent the development of microalbuminuria: is it new? Is it true? Is it important?. Am. J. Kidney Dis [print-electronic]. 2011 Nov; 58(5): 700-3. PMID: 21802806, PII: S0272-6386(11)01055-9, DOI: 10.1053/j.ajkd.2011.07.001, ISSN: 1523-6838.

Lewis EJ, Lewis JB, Greene T, Hunsicker LG, Berl T, Pohl MA, de Zeeuw D, Heerspink HL, Rohde RD, Atkins RC, Reutens AT, Packham DK, Raz I, . Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial. Am. J. Kidney Dis [print-electronic]. 2011 Nov; 58(5): 729-36. PMID: 21872376, PII: S0272-6386(11)01059-6, DOI: 10.1053/j.ajkd.2011.06.020, ISSN: 1523-6838.

Basford AW, Lewis J, Dwyer JP, Fogo AB. Membranous nephropathy with crescents. J. Am. Soc. Nephrol [print-electronic]. 2011 Oct; 22(10): 1804-8. PMID: 21903992, PII: ASN.2010090923, DOI: 10.1681/ASN.2010090923, ISSN: 1533-3450.

Kershaw TS, Arnold A, Lewis JB, Magriples U, Ickovics JR. The skinny on sexual risk: the effects of BMI on STI incidence and risk. AIDS Behav. 2011 Oct; 15(7): 1527-38. PMID: 20976536, PMCID: PMC3158959, DOI: 10.1007/s10461-010-9842-5, ISSN: 1573-3254.

Morgado P, Laginhas CM, Lewis JB, McCabe C, Martins LF, Filipe EJ. Viscosity of liquid perfluoroalkanes and perfluoroalkylalkane surfactants. J Phys Chem B [print-electronic]. 2011 Jul 7/28/2011; 115(29): 9130-9. PMID: 21634410, DOI: 10.1021/jp201364k, ISSN: 1520-5207.

Weir AB, Lewis JB, Arteta-Bulos R. Chronic idiopathic neutrophilia: experience and recommendations. South. Med. J. 2011 Jul; 104(7): 499-504. PMID: 21886049, PII: 00007611-201107000-00008, DOI: 10.1097/SMJ.0b013e31821ec7cc, ISSN: 1541-8243.

Holtkamp FA, de Zeeuw D, de Graeff PA, Laverman GD, Berl T, Remuzzi G, Packham D, Lewis JB, Parving HH, Lambers Heerspink HJ. Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials. Eur. Heart J [print-electronic]. 2011 Jun; 32(12): 1493-9. PMID: 21421598, PII: ehr017, DOI: 10.1093/eurheartj/ehr017, ISSN: 1522-9645.

Booth BD, Vilt SG, Lewis JB, Rivera JL, Buehler EA, McCabe C, Jennings GK. Tribological durability of silane monolayers on silicon. Langmuir [print-electronic]. 2011 May 5/17/2011; 27(10): 5909-17. PMID: 21513320, DOI: 10.1021/la104778q, ISSN: 1520-5827.

Persson F, Lewis JB, Lewis EJ, Rossing P, Hollenberg NK, Parving HH. Aliskiren in combination with losartan reduces albuminuria independent of baseline blood pressure in patients with type 2 diabetes and nephropathy. Clin J Am Soc Nephrol [print-electronic]. 2011 May; 6(5): 1025-31. PMID: 21350110, PMCID: PMC3087767, PII: CJN.07590810, DOI: 10.2215/CJN.07590810, ISSN: 1555-905X.

. Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals. J. Hypertens. 2011 Apr; 29(4): 623-35. PMID: 21358417, DOI: 10.1097/HJH.0b013e328344a7de, ISSN: 1473-5598.

Brackett MG, Lewis JB, Messer RL, Lei L, Lockwood PE, Wataha JC. Dysregulation of monocytic cytokine secretion by endodontic sealers. J. Biomed. Mater. Res. Part B Appl. Biomater [print-electronic]. 2011 Apr; 97(1): 49-57. PMID: 21290574, DOI: 10.1002/jbm.b.31785, ISSN: 1552-4981.

Sipsma HL, Ickovics JR, Lewis JB, Ethier KA, Kershaw TS. Adolescent pregnancy desire and pregnancy incidence. Womens Health Issues [print-electronic]. 2011 Mar; 21(2): 110-6. PMID: 21177123, PMCID: PMC3052996, PII: S1049-3867(10)00125-8, DOI: 10.1016/j.whi.2010.09.004, ISSN: 1878-4321.

McCoy AB, Waitman LR, Gadd CS, Danciu I, Smith JP, Lewis JB, Schildcrout JS, Peterson JF. A computerized provider order entry intervention for medication safety during acute kidney injury: a quality improvement report. Am. J. Kidney Dis [print-electronic]. 2010 Nov; 56(5): 832-41. PMID: 20709437, PMCID: PMC2963668, PII: S0272-6386(10)01048-6, DOI: 10.1053/j.ajkd.2010.05.024, ISSN: 1523-6838.

Toto RD, Greene T, Hebert LA, Hiremath L, Lea JP, Lewis JB, Pogue V, Sika M, Wang X, . Relationship between body mass index and proteinuria in hypertensive nephrosclerosis: results from the African American Study of Kidney Disease and Hypertension (AASK) cohort. Am. J. Kidney Dis. 2010 Nov; 56(5): 896-906. PMID: 20801567, PMCID: PMC4517588, PII: S0272-6386(10)01035-8, DOI: 10.1053/j.ajkd.2010.05.016, ISSN: 1523-6838.

Persson F, Lewis JB, Lewis EJ, Rossing P, Hollenberg NK, Parving HH, . Impact of baseline renal function on the efficacy and safety of aliskiren added to losartan in patients with type 2 diabetes and nephropathy. Diabetes Care [print-electronic]. 2010 Nov; 33(11): 2304-9. PMID: 20693353, PMCID: PMC2963484, PII: dc10-0833, DOI: 10.2337/dc10-0833, ISSN: 1935-5548.

Brackett MG, Messer RL, Lockwood PE, Bryan TE, Lewis JB, Bouillaguet S, Wataha JC. Cytotoxic response of three cell lines exposed in vitro to dental endodontic sealers. J. Biomed. Mater. Res. Part B Appl. Biomater. 2010 Nov; 95(2): 380-6. PMID: 20862766, DOI: 10.1002/jbm.b.31727, ISSN: 1552-4981.

Appel LJ, Wright JT, Greene T, Agodoa LY, Astor BC, Bakris GL, Cleveland WH, Charleston J, Contreras G, Faulkner ML, Gabbai FB, Gassman JJ, Hebert LA, Jamerson KA, Kopple JD, Kusek JW, Lash JP, Lea JP, Lewis JB, Lipkowitz MS, Massry SG, Miller ER, Norris K, Phillips RA, Pogue VA, Randall OS, Rostand SG, Smogorzewski MJ, Toto RD, Wang X, . Intensive blood-pressure control in hypertensive chronic kidney disease. N. Engl. J. Med. 2010 Sep 9/2/2010; 363(10): 918-29. PMID: 20818902, PMCID: PMC3662974, DOI: 10.1056/NEJMoa0910975, ISSN: 1533-4406.

Lewis JB. Blood pressure control in chronic kidney disease: is less really more?. J. Am. Soc. Nephrol [print-electronic]. 2010 Jul; 21(7): 1086-92. PMID: 20576804, PII: ASN.2010030236, DOI: 10.1681/ASN.2010030236, ISSN: 1533-3450.

Siew ED, Matheny ME, Ikizler TA, Lewis JB, Miller RA, Waitman LR, Go AS, Parikh CR, Peterson JF. Commonly used surrogates for baseline renal function affect the classification and prognosis of acute kidney injury. Kidney Int [print-electronic]. 2010 Mar; 77(6): 536-42. PMID: 20042998, PMCID: PMC2929703, PII: ki2009479, DOI: 10.1038/ki.2009.479, ISSN: 1523-1755.

Hung AM, Crawford DC, Griffin MR, Brown-Gentry K, Lipkowitz MS, Siew ED, Cavanaugh K, Lewis JB, Ikizler TA, . CRP polymorphisms and progression of chronic kidney disease in African Americans. Clin J Am Soc Nephrol [print-electronic]. 2010 Jan; 5(1): 24-33. PMID: 19965533, PMCID: PMC2801650, PII: CJN.01900309, DOI: 10.2215/CJN.01900309, ISSN: 1555-905X.

Go AS, Parikh CR, Ikizler TA, Coca S, Siew ED, Chinchilli VM, Hsu CY, Garg AX, Zappitelli M, Liu KD, Reeves WB, Ghahramani N, Devarajan P, Faulkner GB, Tan TC, Kimmel PL, Eggers P, Stokes JB, . The assessment, serial evaluation, and subsequent sequelae of acute kidney injury (ASSESS-AKI) study: design and methods. BMC Nephrol. 2010; 11: 22. PMID: 20799966, PMCID: PMC2944247, PII: 1471-2369-11-22, DOI: 10.1186/1471-2369-11-22, ISSN: 1471-2369.

Dwyer JP, Greco BA, Lewis JB. Evaluation of renal artery stenosis in dialysis patients. Semin Dial [print-electronic]. 2009 Sep; 22(5): 519-23. PMID: 19558627, PII: SDI618, DOI: 10.1111/j.1525-139X.2009.00618.x, ISSN: 1525-139X.

Bhave G, Lewis JB, Chang SS. Association of gadolinium based magnetic resonance imaging contrast agents and nephrogenic systemic fibrosis. J. Urol [print-electronic]. 2008 Sep; 180(3): 830-5; discussion 835. PMID: 18635232, PMCID: PMC4128001, PII: S0022-5347(08)01225-1, DOI: 10.1016/j.juro.2008.05.005, ISSN: 1527-3792.

Basi S, Lewis JB. Microalbuminuria as a target to improve cardiovascular and renal outcomes in diabetic patients. Curr. Diab. Rep. 2007 Dec; 7(6): 439-42. PMID: 18255007, ISSN: 1534-4827.

Basi S, Lewis JB. Microalbuminuria as a target to improve cardiovascular and renal outcomes. Am. J. Kidney Dis. 2006 Jun; 47(6): 927-46. PMID: 16731288, PII: S0272-6386(06)00439-2, DOI: 10.1053/j.ajkd.2006.02.182, ISSN: 1523-6838.

Fischbach BV, Trout KL, Lewis J, Luis CA, Sika M. WAGR syndrome: a clinical review of 54 cases. Pediatrics. 2005 Oct; 116(4): 984-8. PMID: 16199712, PII: 116/4/984, DOI: 10.1542/peds.2004-0467, ISSN: 1098-4275.

Lewis J, Greene T, Appel L, Contreras G, Douglas J, Lash J, Toto R, Van Lente F, Wang X, Wright JT, . A comparison of iothalamate-GFR and serum creatinine-based outcomes: acceleration in the rate of GFR decline in the African American Study of Kidney Disease and Hypertension. J. Am. Soc. Nephrol. 2004 Dec; 15(12): 3175-83. PMID: 15579521, PII: 15/12/3175, DOI: 10.1097/01.ASN.0000146688.74084.A3, ISSN: 1046-6673.

Smith JP, Lewis JB. Hypertension management: special considerations in chronic kidney disease patients. Curr. Hypertens. Rep. 2004 Dec; 6(6): 462-8. PMID: 15527692, ISSN: 1522-6417.

Merrell K, Southwick K, Graves SW, Esplin MS, Lewis NE, Thulin CD. Analysis of low-abundance, low-molecular-weight serum proteins using mass spectrometry. J Biomol Tech. 2004 Dec; 15(4): 238-48. PMID: 15585820, PMCID: PMC2291707, PII: 15/4/238, ISSN: 1524-0215.

Nigbor DA, Lewis JB. Use of calcium antagonists in renal patients: therapeutic benefit or medical malpractice?. Curr. Hypertens. Rep. 2003 Oct; 5(5): 430-6. PMID: 12948437, ISSN: 1522-6417.

Gassman JJ, Greene T, Wright JT, Agodoa L, Bakris G, Beck GJ, Douglas J, Jamerson K, Lewis J, Kutner M, Randall OS and Wang SR for the AASK Group. Design and Statistical Aspects of the African American Study of Kidney Disease and Hypertension (AASK). JASN 14:, 2003. JASN. 2003; 14.

Beddhu S, Kaysen GA, Yan G, Sarnak M, Agodoa L, Ornt D, Cheung AK for the HEMO Study Group. Association of serum albumin and atherosclerosis in chronic hemodialysis patients. American Journal of Kidney Disease. 2002; 4((40)): 721-7.

Cheung AK, Yan G, Greene T, Daugirdas JT, Dwyer JT, Levin NW, Ornt DB, Schulman G, Eknoyan G and the HEMO Study Group. Seasonal Variations in Clinical and Laboratory Variables among Chronic Hemodialysis Patients.. Journal of the American Society of Nephrology. 2002; 13: 2345-52.

Rocco MV, Yan G, Gassman JJ, Lewis JB, Ornt D, Weiss B, Levey AS and the HEMO Study Group. Comparison of causes of death using HEMO Study and HCFA ESRD death notification classification systems. American Journal of Kidney Disease. 2002; 1((39)): 146-53.

Rocco MV, Paranandi L, Burrowes JD, Cockram DB, Dwyer JT, Kusek JW, Leung J, Makoff R, Maroni B, Poole D and the HEMO Study Group. Nutritional Status in the HEMO Study cohort at baseline. 39(2):245-256, 2002. American Journal of Kidney Disease. 2002; 2((39)): 245-56.

Burrowes JD, Cockram DB, Dwyer JT, Larive B, Paranandi L, Bergen C, Poole D and the HEMO Study Group. Cross-sectional relationship between dietary protein and energy intake, nutritional status, functional status and comorbidity in older vs. younger hemodialysis patients. Journal of Renal Nutrition. 2002; 2((12)): 87-95.

Allen KL, Miskulin D, Guofen Y, Dwyer JT, Frydrych A, Leung J, Poole D and the Hemodialysis (HEMO) Study Group. Association of nutritional markers with physical and mental health in prevalent hemodialysis patients from the HEMO Study. Journal of Renal Nutrition. 2002; 3((12)): 160-9.

Agodoa L, Appel L, Charleston J, Bakris, G, Cheek D, Douglas-Baltimore J, Gassman J, Glassock R, Greene T, Hebert L, Jamerson K, Lewis J, Phillips R, Toto R, Wright J. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK Trial. Journal of the American Medical Association. 2002; 288: 2421-31.

Wright JT, Agodoa L, Contreras G, Greene T, Douglas JG, Lash J, Randall O, Rogers N, Smith MC, Massry S and the AASK Study Group. Achieved blood pressure control in the African American Study of Kidney Disease and Hypertension (AASK). 2002; 162((Archives of Internal Medicine.)): 1636-43.

Kusek J, Greene P, Wang S-R, Beck G, West D, Jamerson K, Agodoa L, Faulkner M, Level B, and the AASK Study Group. Cross-sectional study of health-related quality of life in African Americans with chronic renal insufficiency: The African American Study of Kidney Disease and Hypertension (AASK) Trial. American Journal of Kidney Diseases. 2002; 39: 513-24.

Leypoldt JK, Cheung AK, Delmez JA, Gassman JJ, Levin NW, Lewis JB, Lewis JL, Rocco MV, and the HEMO Study Group. Relationship between volume status and blood pressure during chronic hemodialysis. Kidney International. 2002; 61,1: 266-75.

Lewis J, Agodoa L, Cheek D, Greene T, Middleton J, O'Connor D, Ojo A, Phillips R, Sika M, Wright J, . Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate. Am. J. Kidney Dis. 2001 Oct; 38(4): 744-53. PMID: 11576877, PII: S0272638601488639, ISSN: 1523-6838.

Lewis J, Lewis EJ. In memory of a legendary athlete: measured success in diabetic nephropathy. Semin. Nephrol. 2001 Mar; 21(2): 124-32. PMID: 11245775, PII: S0270929501000158, ISSN: 0270-9295.

Lewis J and Lewis EJ. In Memory of a Legendary Athlete: Measured Success in Diabetic Nephropathy. Semin Nephrol. 2001; 21: 124-32.

Agodoa LY, Appel L, Bakris GL et al. Effect of Ramipril vs Amlodipine on Renal Outcomes in Hypertensive Nephrosclerosis. A Randomized Controlled Trial. JAMA Express. 2001; 285: June 6, 2001.

Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I for the Collaborative Study Group. Renoprotective Effect of the Angiotensin Receptor Antagonist Irbesartan in Type 2 Diabetic Nephropathy". N Engl J Med. 2001; 345: 851-60.

Lewis J, Agodoa L, Cheek D, Greene T, Middleton J, O'Connor D, Ojo A, Phillips R, Sika M, Wright J Jr. for the AASK Study Group. Comparison of Crossectional Renal Function Measurements in African-Americans with Hypertensive Nephrosclerosis and of Primary Formulas to Estimate GFR. American Journal of Kidney Diseases. 2001; 38((4)): 744-53.

Lewis J, Salem MM, Chertow GM, Weisberg LS, McGrew F, Marbury TC, Allgren RL. Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group. Am. J. Kidney Dis. 2000 Oct; 36(4): 767-74. PMID: 11007679, PII: S0272638600632031, ISSN: 1523-6838.

Lewis JB, Berl T, Bain RP, Rohde RD, Lewis EJ. Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group. Am. J. Kidney Dis. 1999 Nov; 34(5): 809-17. PMID: 10561135, PII: S0272638699003820, ISSN: 0272-6386.

Broumand V, Paueksakon P, Lewis JB, Nadeau J, Fogo A. A 19-year-old man with hypertension, proteinuria, and renal insufficiency. Am. J. Kidney Dis. 1999 Oct; 34(4): 768-74. PMID: 10516364, PII: S0272-6386(99)70407-5, DOI: 10.1016/S0272-6386(99)70407-5, ISSN: 1523-6838.

Lewis JB. Diabetic nephropathy in patients with type II diabetes. Geriatr Nephrol Urol. 1999; 9(3): 167-75. PMID: 10701139, ISSN: 0924-8455.

Levey AS, Bosch JP, Breyer-Lewis J, Greene T, Rogers N, Roth D and the MDRD Study Group. A more accurate methods to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Annals of Internal Medicine. 1999; 130: 461-70.

Lewis JB, Berl T, Bain RP, Rohde RD, Lewis EJ and the Collaborative Study Group. Effect of intensive blood pressure control on the course of Type I diabetic Nephropathy. Am J Kidney Dis. 1999; 34: 1-10.

Lewis JB. Microalbuminuria: accuracy or economics. Am. J. Kidney Dis. 1998 Sep; 32(3): 524-8. PMID: 9740175, PII: S0272638698002637, ISSN: 1523-6838.

Coggins CH, Breyer JA, Caggiula AW, Castaldo LS, Klahr S, Wang SR. Differences between women and men with chronic renal disease. [Clinical Trial. Journal Article. Multicenter Study. Randomized Controlled Trial] Nephrology, Dialysis, Transplantation. 1998; 13((6)): 1430-7.

Schwartz MM, Lewis EJ, Leonard-Martin T, Lewis JB, Battle D and the Collaborative Study Group. Renal Pathology in Type II Diabetes Mellitus: Relationship with retinopathy. Nephrol Dial Transplant. 1998; 13((10)): 2547-52.

*Allgren RL, Marbury TC, Rahman SN, Weisberg LS, Fenves AZ, Lafayettes RA, Sweet RM, Genter FC, Kurnik BRC, Conger JD, Sayegh MH for the Auriculin Anaritide Acute Renal Failure Study Group. Anaritide in Acute Tubular Necrosis. NEJM. 1997; 336: 828-34.

Coomer RW, Schulman G, Breyer JA, Shyr Y. Ambulatory Blood Pressure Monitoring in Dialysis Patients and Estimation of Mean Inter-Dialytic Blood Pressure. Am J Kidney Dis. 1997; 29((5)): 678-84.

Fogo A, Breyer JA, Smith MC, Cleveland WH, Agodoa L, Kirk KA, Glassock R and the AASK Pilot Study Investigators. Accuracy of the Diagnosis of Hypertensive Nephrosclerosis in African Americans: A Report from the African American Study of Kidney Disease (AASK) Trial. Kidney Int. 1997; 51: 244-52.

Hebert LA, Kusek JW, Greene T, Agodoa LY, Jones CA, Breyer JA, Faubert P, Rolin HA, Wang SR. Differences Between Blacks and Whites in the Effect of Blood Pressure Control on the Progression of Renal Disease in the Modification of Diet in Renal Disease Study. Hypertension. 1997; 30(Pt1): 428-35.

Breyer JA, Bain R., Evans, JK, Nahman NS, et al. Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. Kidney Int. 1996; 50: 1651-8.

Klahr S, Breyer JA, Beck G, Dennis V, Hartman J, Roth D, Yamamoto M and MDRD Study Group. Dietary Protein Restriction, Blood Pressure Control of Renal Function in the Progress of Polycystic Kidney Disease. JASN. 1995; 5: 2037-47.

Eknoyan G, Breyer JA, Nissenson A, Beck G, Schulman G, Kusek J. Response to: Wasserstein AG, The Mortality and Morbidity in Hemodialysis Study: Ethical issues. Seminars in Dialysis. 1995; 7: 369-72.

Breyer JA, Hunsicker LG, Bain R., Lewis EJ and The Collaborative Study Group. Angiotensin Converting Enzyme Inhibition in Diabetic Nephropathy. Kidney Int. 1994; 45((45)): S156-S160.

Ikizler TA, Wingard RL, Breyer JA, Schulman G, Parker RA, Hakim RM. Short-term effects of recombinant human growth hormone in CAPD patients. Kidney Int. 1994; 46: 1178-83.

Breyer JA, Harbison MA. Isolation of Human Immunodeficiency Virus from Peritoneal Dialysate. Am J Kidney Dis. 1993; 21((1)): 23-5.

Lewis EJ, Hunsicker LG, Bain R., Rohde RD for the Collaborative Study Group. The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy. N Engl J Med. 1993; 329: 1456-62.

Breyer JA. Diabetic Nephropathy in Insulin-Dependent Patients. Am J Kidney Dis. 1992; 20((6)): 533-47.